Remdesivir for treatment of COVID-19 patients

  Remdesivir , is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease. The COVID-19 disease is relatively new and as this drug has seen significant usage in hospitalized patients, there is a need for clinicians to share their experiences on the topic. Indian Medical...

Benefit of early intervention & role of Favipiravir in managing mild to moderate COVID-19 disease

  As the incidence of COVID-19 cases continue to rise, we will need multiple approaches to effectively deal with this pandemic. Clinicians are evaluating Favipiravir for use in mild-to-moderate COVID-19 disease, which if administered early, may shorten time to recovery and keep the infection from progressing into severe disease. We welcome you to watch a recorded experience sharing...

Remdesivir for the Treatment of Severe COVID-19

  Welcome to an exciting international exchange of experiences on "Remdesivir for the Treatment of Severe COVID-19"; the live webinar was held on 28th August 2020.  In India, Remdesivir has been approved for emergency use in patients hospitalized with severe COVID-19 and has shown promising results. There is a need to more critically understand the utility of this drug,...

The race for COVID-19 treatment, Clinical trial outcomes & expert perspectives

The challenges of conducting trials against the backdrop of the COVID-19 pandemic will continue as we collectively journey into the “new normal”.  Welcome to the recorded webinar on "The race for COVID-19 treatment; Clinical trial outcomes & expert perspectives". What will be covered: Situation of COVID-19 and health care workers in the state of Uttar Pradesh...